A double blind, placebo-controlled randomized trial of low-dose risperidone, cognitive-behaviour therapy, and supportive therapy in young people at ultra high risk of psychotic disorder: 12 month outcome data

被引：0
|
作者：
Yung, A. R. [1 ,2 ]
Nelson, B. [2 ]
Phillips, L. [3 ]
Francey, S. [2 ]
Leicester, S. [2 ]
Yuen, H. P. [1 ,2 ]
Simmons, M. [1 ,2 ]
Berger, G. [2 ]
Amminger, P. [1 ,2 ]
McGorry, P. D. [1 ,2 ]
机构：
[1] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia
[2] ORYGEN Res Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2008年 / 2卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 50 条
  • [41] A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial
    Stain, Helen J.
    Bucci, Sandra
    Baker, Amanda L.
    Carr, Vaughan
    Emsley, Richard
    Halpin, Sean
    Lewin, Terry
    Schall, Ulrich
    Clarke, Vanessa
    Crittenden, Kylie
    Startup, Mike
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 212 - 219
  • [42] Does high-dose lovastatin therapy diminish the risk of iodinated contrast induced acute kidney injury? A double-blind placebo-controlled clinical trial
    Forghani, Mohammad Saad
    Fathizade, Khaled
    Vahedi, Siamak
    Ataei, Sara
    Roshani, Daem
    JOURNAL OF RENAL INJURY PREVENTION, 2018, 7 (02): : 94 - 97
  • [43] Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial
    Humrich, Jens Y.
    Cacoub, Patrice
    Rosenzwajg, Michelle
    Pitoiset, Fabien
    Hang Phuong Pham
    Guidoux, Joel
    Leroux, David
    Vazquez, Thomas
    Riemekasten, Gabriela
    Smolen, Josef S.
    Tsokos, George
    Klatzmann, David
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) : 1685 - 1694
  • [44] Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial
    Diguisto, Caroline
    Le Gouge, Amelie
    Marchand, Marie-Sara
    Megier, Pascal
    Ville, Yves
    Haddad, Georges
    Winer, Norbert
    Arthuis, Chloe
    Doret, Muriel
    Debarge, Veronique Houfflin
    Flandrin, Anaig
    Delmas, Helene Laurichesse
    Gallot, Denis
    Mares, Pierre
    Vayssiere, Christophe
    Sentilhes, Loic
    Cheve, Marie-Therese
    Paumier, Anne
    Durin, Luc
    Schaub, Bruno
    Equy, Veronique
    Giraudeau, Bruno
    Perrotin, Franck
    PLOS ONE, 2022, 17 (10):
  • [45] Effect of Low-Level Laser Therapy on Muscle Strength and Endurance and Post-Exercise Recovery of Young Adult: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
    Yekta, Amir Hosein Abedi
    Tabeii, Faraj
    Salehi, Shahin
    Sohrabi, Mohammad-Reza
    Poursaeidesfahani, Mehrshad
    Hassabi, Mohammad
    Hazegh, Nina
    Mandaviani, Behnaz
    ANNALS OF APPLIED SPORT SCIENCE, 2021, 9 (02): : 1 - 9
  • [46] Repeated low-dose caffeine ingestion during a night of total sleep deprivation improves endurance performance and cognitive function in young recreational runners: A randomized, double-blind, placebo-controlled study
    Khcharem, Amir
    Souissi, Wajdi
    Masmoudi, Liwa
    Sahnoun, Zouheir
    CHRONOBIOLOGY INTERNATIONAL, 2022, 39 (09) : 1268 - 1276
  • [47] Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial
    Laetitia Vanderijst
    Felix Hever
    Anne Buot
    Charles Dauré
    Janaïna Benoit
    Catherine Hanak
    Johannes Veeser
    Margot Morgiève
    Salvatore Campanella
    Charles Kornreich
    Luc Mallet
    Christophe Leys
    Xavier Noël
    BMC Psychiatry, 24
  • [48] Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial
    Vanderijst, Laetitia
    Hever, Felix
    Buot, Anne
    Daure, Charles
    Benoit, Janaina
    Hanak, Catherine
    Veeser, Johannes
    Morgieve, Margot
    Campanella, Salvatore
    Kornreich, Charles
    Mallet, Luc
    Leys, Christophe
    Noel, Xavier
    BMC PSYCHIATRY, 2024, 24 (01)
  • [49] Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
    Zhu, Ming-Huan
    Liu, Zhen-Jing
    Hu, Qiong-Yue
    Yang, Jia-Yu
    Jin, Ying
    Zhu, Na
    Huang, Ying
    Shi, Dian-Hong
    Liu, Min-Jia
    Tan, Hong-Yang
    Zhao, Lei
    Lv, Qin-Yu
    Yi, Zheng-Hui
    Wu, Feng-Chun
    Li, Ze-Zhi
    MILITARY MEDICAL RESEARCH, 2022, 9 (01)
  • [50] Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
    Ming-Huan Zhu
    Zhen-Jing Liu
    Qiong-Yue Hu
    Jia-Yu Yang
    Ying Jin
    Na Zhu
    Ying Huang
    Dian-Hong Shi
    Min-Jia Liu
    Hong-Yang Tan
    Lei Zhao
    Qin-Yu Lv
    Zheng-Hui Yi
    Feng-Chun Wu
    Ze-Zhi Li
    Military Medical Research, 2023, (04) : 431 - 443
12345